A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically ...

Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

To accelerate discovery, scientists from ATCC and the Broad Institute collaborated to engineer a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...

In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

ImmunoScape presented compelling new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2026.

In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk. The model, called ...